"Ecstasy": A pharmacological review;"Êxtase": Revisão farmacológica

Revista de Saude Publica

Volumn 32, Issue 5, 1998, Pages 487-495

  Ferigolo, Maristela ^a,b   Medeiros, Fernanda B ^a   Barros, Helena M T ^a  

^a Division of Pharmacology Fund Faculdade Fed de Cie M Sarmento Leite   (Brazil)

^b NONE   (Brazil)

Author keywords

N methyl 3.4 methylenedioxy, adverse effects; Self administration; Substance Related disorders

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PSYCHEDELIC AGENT;

ADDICTION; HUMAN; REVIEW; DRUG DETERMINATION; DRUG EFFECT; PREVALENCE; SUBSTANCE ABUSE;

HALLUCINOGENS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 0032176865     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89101998000500014     Document Type: Review

References (49)

1. AMERICAN PSYCHIATRIC ASSOCIATION.Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC, 1995. p. 175-272.
2. BENAZZI, F. & MAZZOLI, M. Psychiatry illness associated with "ecstasy". Lancet, 338: 1520, 1991.
3. BROWN, C. & OSTERLOH, J. Multiple severe complications from recreational ingestion of MDMA ("Ecstasy"). JAMA, 258: 780-1, 1987.
4. BUFFUM, J. & MOSER, C. MDMA and human sexual function. J. Psychoactive Drugs, 18: 355-9, 1986.
5. CAMI, J.; DEL AL TORRE, R.; ORTUÑO, J.; FARRÉ, M.; MAS, M.; ROSET, P.N.; SEGURA, J. Pharmacokinetics of ecstasy (MDMA) in healthy subjects. Eur. J. Clin. Pharmacol., 52 (Suppl.) 168, 1997.
6. CUOMO, M.J.; DYMENT, P.G.; GAMMINO, V.M. Increasing use of "ecstasý (MDMA) and other hallucinogens on a college campus. J. Am. Coll. Health, 42: 271-4, 1994.
7. CREIGHTON, F.; BLACK, D.; HYDE, C. "Ecstasy" psychosis and flashbacks. Br. J. Psychiatry, 159: 713-5, 1991.
8. DOWNING, J. The psychological and physiological effects of MDMA on normal volunteers. J. Psychoactive Drugs, 18: 335-40, 1986.
9. DOWLING, G.; McDONOUGH, E.; BOST, R. "Eve" and "ecstasy": a report of five deaths associated with the use of MDEA and MDMA. JAMA, 257: 1615-7, 1987.
10. GREEN, A.R.; CROSS, A.J.; GOODWIN, G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology, 119: 247-60, 1995.
11. GREER, G. & STRASSMAN, R. Information on "ecstasy". Am. J. Psychiatry, 142: 1391, 1985.
12. GREER, G. & TOLBERT, R. Subjective reports of the effects of MDMA in a clinical setting. J. Psychoactive Drugs, 18: 319-27, 1986.
13. GRISPOON, L. & BAKALAR, J. Can drugs be used to enhance the psychotherapeutic process? Am. J. Psychoter., 40: 393-404, 1986.
14. HAYNER, G.N. & McKINNEY, H. MDMA the dark side of ecstasy. J. Psychoactive Drugs, 18: 341-7, 1986.
15. HENRY, J. Ecstasy and the dance of death. BMJ, 305: 5-6, 1992.
16. HENRY, J.; JEFFREYS, K.; DAWLING, S. Toxicity and deaths from 3,4-methylenedimethoxymethamphetamine ("ecstasy"). Lancet, 340: 384-7, 1992.
17. LARANJEIRA, R.; DUNN, J.; RASSI, R.; FERNANDES, M. "Êxtase" (3,4 metilenodioximetanfetamina, MDMA): uma droga velha e um problema novo? ABP-APAL 18(3): 77-81, 1996.
18. LIESTER, M.; GROB, C.; BRAVO, G.; WALSH, R. Phenomenology and sequelae of 3,4-methylenedimethoxymethamphetamine use. J. Nerv. Ment. Dis., 180: 345-52, 1992.
19. MANSUR, J.& CARLINI, E.A. Drogas subsídios para uma discussão. São Paulo, Ed. Brasiliense, 1989.
20. MARONA-LEWICKA, D.; RHEE, G.; SPRAGUE, J.E.; NICHOLS, D.E. Reinforcing effects os certain serotonin-releasing amphetamine derivates. Pharmacol. Biochem. Behav., 53: 99-105, 1996.
21. MARSH, J.C.W.; ABBOUDI, Z.H.; GIBSON, F.M.; SCOPES, J.; DALY, S.; O'SHAUNNESSY, D.F.; BAUGHAN, A.S.J.; GORDON-SMITH, E.C. Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ("Ecstasy"). Br. J. Haematol., 88: 281-5, 1994.
22. MASCARÓ, B.I.; AZNAR, B.A.; SERRANO, G.J.; LOPEZ-BRIZ, E.; MARTINI-BONMATI, E. MDMA "extasis": revisión y puesta al día. Rev. Esp. Drogodep., 16: 91-101, 1991.
23. McCANN, U. & RICAURTE, G. Lasting neuropsychiatric sequelae of methylenedimethoxymethamphetamine ("ecstasy") in recreational users. J. Clin. Psychopharmacol., 11: 302-5, 1991.
24. McGUIRE, P. & FAHY, T. Chronic paranoid psychosis after misuse of MDMA ("ecstasy"). BMJ, 302: 697, 1991.
25. McGUIRE, P.; COPE, H.; FAHY, T. Diversity of psychopathology associated with use of 3,4-methylenedimethoxymethamphetamine ("ecstasy"). Br. J. Psychiatry, 165: 391-5, 1994.
26. MCKENNA, D.J. & PEROUTKA, S.J. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). J. Neurochem., 54: 14-22, 1990.
27. MUNIESA, H. & ROYO, P. Hepatitis aguda tras consumo de éxtasis. Rev. Esp. Enf. Digest., 87: 681-3, 1995.
28. NICHOLS, D.E. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J. Psychoactive Drugs, 18: 305-13, 1986.
29. OLSON, K.R., ed. Poisoning and drug overdose. California, Appleton & Lange, 1990.
30. PEROUTKA, S. "Ecstasy": a human neurotoxin? Arch. Gen. Psychiatry, 46: 191, 1989.
31. PEROUTKA, S.Incidence of recreational use of 3,4 methylenedimethoxymethamphetamine (MDMA, "Ecstasy") on an Undergraduate campus. N. Engl J. Med., 317: 1542-3, 1987.
32. PIERCEY, M. F.; LUM, J.T.; PALMER, J.R. Effects of MDMA ("ecstasy") on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat. Brain Res., 526: 203-6, 1990.
33. RANDALL, T. Ecstasy-fueled "rave" parties become dances of death for english youths. J. Am. Med. Assoc., 268:1505-6, 1992.
34. RECCIA, L.; ROCCO, A.; LIONIELLO, M.; FICHERA, G. Amphetamine misuse in southern Italy. BMJ, 311: 1433, 1995.
35. RICAURTE, G.A.; FORNO, L.S.; WILSON, M.A.; DELANNEY, L.E.; IRWIN, I.; MOLLIVER, M.E.; LANGSTON, J.W. (+/_)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. J. Am. Med. Assoc., 260: 51-5, 1988.
36. ROBINSON, T.E.; CASTANEDA, E.; WHISHAW, I.Q. Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade. Neuropsychopharmacology, 8: 77-85, 1993.
37. RUSSEL, A.; SCHWARTZ, R.; DAWLING, S. Accidental ingestion of "ecstasy" (3,4-methylenedimethoxymethamphetamine). Arch. Dis. Child., 67: 1114-5, 1992.
38. SCHIFANO, F. & MAGNI, G. MDMA (ecstasy) abuse: psychopathological features and craving for chocolate; a case series. Biol. Psychiatry, 36: 763-7, 1994.
39. SCREATON, G.R.; SINGER, M.; CAIRNS, H.S.; THRASHER, A.; SARNER, M. Hyperpyrexia and rhabdomyolysis after MDMA (ecstasy) abuse. Lancet, 339: 677-8, 1992.
40. SHAPER, A.G. Walking on the moon. Lancet, 347: 207-8, 1996.
41. SHEARMAN, J.D.; CHAPMAN, R.W.G.; SATSANGI, J.; RYLEY, N.G.; WEATHERHEAD, S. Misuse of Ecstasy. BMJ, 305: 309-10, 1992.
42. SHULGIN, A.T. The backgroung and chemistry of MDMA. J. Psychoactive Drugs, 18: 291-304, 1986.
43. SIEGEL, R.K. MDMA nonmedical use and intoxication. J. Psychoactive Drugs, 18: 349-54, 1986.
44. SQUIER, M.; JALLOH, S.; HILTON-JONES, D.; SERIES, H. Death after ecstasy ingestion: neuropathological findings. J. Neurol. Neurosurg. Psychiatry, 58: 756, 1995.
45. STEELE, T.D.; McCANN, U.D.; RICAURTE, G.A. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction, 89: 539-51, 1994.
46. TACKE, U. & EBERT, M.H. Hallucinogens In: CIRAULO, D.A. & SHADER, R.I. Clinical manual of chemical dependence. Washington, DC., American Psychiatric Press, 1991. p. 259-78.
47. VEREBEY, K.; ALRAZI, J.; JAFRE, J.H. The complications of "ecstasy" (MDMA). JAMA, 259: 1649-50, 1988.
48. WHITAKER-AZMITIA, P. & ARONSON, T. "Ecstasy" (MDMA) Induced panic. Am. J. Psychiatry, 146: 119, 1989.
49. WOLFF, K.; HAY, A.; SHERLOCK, K.; CONNER, M. Contents of "ecstasy". Lancet, 346: 1100-1, 1995.